Comparison of a 22G crown-cut needle with a conventional 22G needle with EBUS guidance in diagnosis of sarcoidosis

Phase 4

• Conditions: D86.0; Sarcoidosis of lung

• Registration Number: DRKS00024714
• Lead Sponsor: Ruhrlandklinik, Westdeutsches Lungenzentrum am Universitätsklinikum Essen gGmbH

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Completion: 2021-01-26
• Study Start: 2021-03-16
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

1. Patients with suspected sarcoidosis
2. Ager= 18 years
3. Signed delcaration of consent

Exclusion Criteria

1. Increased risk of bleeding
a. Known predisposition of bleeding
b. INR> 1.5 or Quick value <60%
c. Increased Partial Thromboplastin Time (PTT)
d. Platelet count <50 / nl
e. Effective use of anticoagulants or
Antiplatelet agents prior to examination
2. Clinically relevant medical or mental illnesses that may affect the patient's judgment and / or his participation in the study
3. Participation in the study not desired

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Comparison of the two needle types with regard to the question of whether the new biopsy needle achieves a better diagnostic accuracy.

Secondary Outcome Measures

Name	Time	Method
Comparison of the two needle types with regard to:<br>- Examination duration<br>- Complications<br>- Weight, composition, macroscopy of the samlpe material<br>- Quality of the sample material